Projects By Category: CNS and GI
Stay up to date with project updates from the CNS and GI|/projects/category/cns-and-gi category.Latest Industry Projects in CNS and GI
Alemtuzumab (marketed as Campath/MabCampath) is an anti-CD52 monoclonal antibody (MAb) for which Bayer HealthCare holds exclusive global marketing rights. It was licensed in 2001 for the...
> read more
Almorexant
Almorexant is the first member of a new class of drugs called orexin receptor antagonists indicated for the treatment of sleep disorders. It was discovered and developed by the Swiss...
APD125 - Therapy for Insomnia
Developed by Arena Pharmaceuticals, APD125 is an oral serotonin antagonist with potential for the treatment of insomnia. In December 2008, Arena announced that APD125 did not meet its primary...
Aubagio (Teriflunomide) for the Treatment of Multiple Sclerosis
Aubagio (teriflunomide) is an immunomodulatory agent indicated for the treatment of relapsing forms of multiple sclerosis (MS). It was developed by...
Change Category
Projects In CNS and GI Alphabetically
- Lamictal – Approved Treatment for Epilepsy and Bipolar, United States of America
- Latuda (lurasidone HCl) for the Treatment of Schizophrenia, United States of America
- Lexapro, Other
- Licofelone - Novel Analgesic and Anti-Inflammatory, Other
- Linzess for the Treatment of Irritable Bowel Syndrome with Chronic Idiopathic Constipation, United States of America
- Lurasidone - Treatment for Schizophrenia and Bipolar Disorder, Japan
- LY2140023 – Treatment of Schizophrenia, Other
- Lyrica (Pregabalin) - New Gabapentinoid with Wide, Other
- Sabril (Vigabatrin) - Treatment for Refractory Complex Partial Seizures and IS, United States of America
- Sativex - Investigational Cannabis-Based treatment for Pain and Multiple Sclerosis, Other
- Semagacestat – Gamma Secretase Inhibitor for Alzheimer's Disease, Other
- Seroquel - Treatment for Major Depressive Disorder (MDD), Other
- Silenor (doxepin) for the Treatment of Insomnia, United States of America
- Sycrest (asenapine) - Treatment for Bipolar I Disorder, United States of America
Twitter
Facebook